Skip to main content

Advertisement

SpringerLink
Log in

Androgens are Fundamental in the Maintenance of Male Sexual Health

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The presence of a sufficient amount of androgens is essential for adequate sexual function in men. Gonadal hormones profoundly affect cognitive functions and, therefore, are fundamental in maintaining sexual desire. The earliest manifestation of hypogonadism is diminished libido. Furthermore, androgens also act peripherally, maintaining the integrity of penile structures and facilitating the erectile mechanisms. Severe androgen deficiency results in anatomical and hemodynamic changes leading to erectile dysfunction that can be corrected with testosterone supplementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Brown-Séquard CE. Note on the effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals. Lancet. 1889;137:105–7.

    Article  Google Scholar 

  2. David K, Dingemanse E, Laqeur E. Uber kristallinisches m männliches Hormon aus Hoden (Testosteron), wirksamer aus Harn oder aus Cholesterin bereitetes Androsteron. Z Physiol Chem. 1935;233:281–7.

    Article  CAS  Google Scholar 

  3. King SR, Manna PR, Ishii T, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci. 2002;15(22):10613–20.

    Google Scholar 

  4. Mulligan T, Iranmanesh A, Feldhuis JD, et al. Pulsatile IV infusion of recombinant human LH in leuprolide suppressed men unmasks impoverished Leydig-cell secretory responsiveness. J Clin Endocrinol Metab. 2001;86:5574–9.

    Article  Google Scholar 

  5. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91:4335–43.

    Article  PubMed  CAS  Google Scholar 

  6. Montejo AL, Majadas S, et al. Frequency of sexual dysfunction in patients with psychotic disorder receiving antipsychotics. J Sex Med. 2010;7:3404–13.

    Article  PubMed  Google Scholar 

  7. Elaut E, Bogaert V, De Cuypere G, et al. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: en exploration in male-to-female transsexuals. J Endocrinol Invest. 2010;33:37–41.

    PubMed  CAS  Google Scholar 

  8. • Gades NM, Jacobson DJ, McGree ME, et al. The association between serum sex hormones, erectile function, and sex drive: The Olmsted County Study of urinary symptoms and health status among men. J Sex Med. 2008;5:2209–20. This study provides strong support to the clinical relevance of androgens and sexual function.

    PubMed  Google Scholar 

  9. Buvat J, Lemaire A. Endocrine screening of 1022 men with erectile dysfunction: clinical significance and cost effective strategy. J Urol. 1997;158:1764–8.

    Article  PubMed  CAS  Google Scholar 

  10. Johri AM, Heaton JPW, Morales A. Severe erectile dysfunction is a marker of hyperprolactinemia. Int J Impot Res. 2001;13:176–9.

    Article  PubMed  CAS  Google Scholar 

  11. Lobo RA, Kletzky OA. Normalization of androgens and sex-hormone-binding globulin levels after treatment of hyperprolactinemia. J Clin Endocrinol Metab. 1982;56:562–6.

    Article  Google Scholar 

  12. • Rowland D, McMahon CG, Abdo C, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7:1668–86. This is an excellent current review of androgens and effect on men’s health.

    Article  PubMed  Google Scholar 

  13. Lauman EO, Paik A, Rosen RC. Sexual dysfunctions in the United States: prevalence and predictors. JAMA. 1999;281:537–44.

    Article  Google Scholar 

  14. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154:502–21.

    Article  PubMed  CAS  Google Scholar 

  15. Corona G, Mannuci E, Lotti F, et al. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. J Sex Med. 2009;6:2591–600.

    Article  PubMed  Google Scholar 

  16. Arteaga-Silva M, Vigueras-Villasenor RM, Retana-Marquez S, et al. Testosterone, androstenedione and 5 alpha-dehydrotestosterone on male sexual behavior and penile spines in the hamster. Physiol Behav. 2008;94:412–21.

    Article  PubMed  CAS  Google Scholar 

  17. Sarkar M, Bora D, Bandopadhayay S, et al. Season of the year influences output and concentration of testosterone in circulation in yaks. Anim Reprod Sci. 2009;115:300–5.

    Article  PubMed  CAS  Google Scholar 

  18. Corona G, Jannini EA, Mannuci E, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5:1991–8.

    Article  PubMed  CAS  Google Scholar 

  19. Heaton JPW, Varrin S, Morales A. The characterization of a bio-assay of erectile function in a rat model. J Urol. 1991;145:1099–102.

    PubMed  CAS  Google Scholar 

  20. Adams MA, Banting JD, Maurice DH, et al. Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple overlapping systems. Int J Impot Res. 1997;9:85–9.

    Article  PubMed  CAS  Google Scholar 

  21. Traish AM, Munarriz R, O’Conell L, et al. Effects of medical or surgical castration on erectile function in an animal model. J Androl. 2003;24:381–7.

    PubMed  Google Scholar 

  22. Morales A, Johnson B, Heaton JPW, et al. Testosterone supplementation in hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol. 1997;157:849–52.

    Article  PubMed  CAS  Google Scholar 

  23. Saad F, Gooren LJ, Haider A, et al. A dose response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl. 2008;29:102–6.

    Article  PubMed  CAS  Google Scholar 

  24. Hwang TI, Lin YC. The relationship between hypogonadism and erectile dysfunction. Int J Impot Res. 2008;20:231–5.

    Article  PubMed  CAS  Google Scholar 

  25. Hirshkowitz M, Moore CA, O’Connor S, et al. Androgens and sleep-related erections. J Psychosom Res. 1997;42:541–7.

    Article  PubMed  CAS  Google Scholar 

  26. Kalinchenko SY, Koslov GI, Gontcharov NP, et al. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus on patients failing on sildenafil citrate therapy alone. Aging Male. 2003;6:94–9.

    PubMed  CAS  Google Scholar 

  27. Rosenthal BD, May NR, Metro MJ, et al. Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology. 2006;67:571–4.

    Article  PubMed  Google Scholar 

  28. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982;2:938.

    Article  PubMed  CAS  Google Scholar 

  29. Brindley GS. Cavernosal alpha blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatr. 1983;143:332–7.

    Article  CAS  Google Scholar 

  30. Brindley GS. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. Br J Psychiatr. 1986;149:210–5.

    Article  CAS  Google Scholar 

  31. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–36.

    PubMed  CAS  Google Scholar 

  32. Saenz de Tejada I. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int J Impot Res. 2002;14 Suppl 1:6–10.

    Article  Google Scholar 

  33. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191–236.

    PubMed  CAS  Google Scholar 

  34. • Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection. J Androl. 2009;30:363–9. This is an informative review of the basic science efforts to elucidate the effect of androgen deprivation in erectile function.

    Article  PubMed  CAS  Google Scholar 

  35. • Bhasin S, Cunningham G, Hayes F, et al. Testosterone therapy in men with androgen deficiency syndromes: En Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:2536–59. This article is essential reading for those treating men with TDS.

    Article  PubMed  CAS  Google Scholar 

  36. Morales A, Bella AJ, Chun S, et al. A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Can Urol Assoc J. 2010;4:269–75.

    PubMed  Google Scholar 

  37. Bhasin S, Coviella A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.

    Article  PubMed  CAS  Google Scholar 

  38. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239–42.

    Article  PubMed  CAS  Google Scholar 

  39. Morales A, Spevack L, Emerson L, et al. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male. 2007;10:57–65.

    Article  PubMed  CAS  Google Scholar 

  40. Hackett G, Kell P, Ralph D, et al. British society for sexual medicine guidelines on the management of erectile dysfunction. J Sex Med. 2008;5:1841–65.

    Article  PubMed  Google Scholar 

  41. Wang C, Nieschlag EE, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009;55:121–30.

    Article  PubMed  Google Scholar 

  42. • Collier C, Morales A, Clark AF, et al. The significance of biological variation in the diagnosis of testosterone deficiency and considerations on the relevance of total, free and bioavailable testosterone determinations. J Urol. 2010;183:2294–8. This is an informative study on the pitfalls of biochemical assays for measuring serum testosterone.

    Article  PubMed  CAS  Google Scholar 

  43. Black A, Day AG, Morales A. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJUI. 2004;94:1066–70.

    Article  Google Scholar 

  44. Morley J. The diagnosis of late life hypogonadism. Aging Male. 2007;10:217–20.

    Article  PubMed  Google Scholar 

  45. Melmed S, Casanova FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactenemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:272–8.

    Article  Google Scholar 

  46. Kupelian V, Shabsigh R, Araujo AB, et al. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts male aging study. J Urol. 2006;176:222–6.

    Article  PubMed  Google Scholar 

  47. Corona G, Monami M, Rastrelli G, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011;8:272–83.

    Article  PubMed  CAS  Google Scholar 

  48. • Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93:69–75. This study refuted the erroneous idea that TDS is merely an inconvenience that does not affect survival or quality of life, a wake-up call for clinicians.

    Google Scholar 

  49. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241–7.

    Article  PubMed  CAS  Google Scholar 

  50. Morales A, Nieschlag E, Schubert M, et al. Clinical experience with the new long-acting injectable testosterone undecanoate. Aging Male. 2006;9:221–7.

    Article  PubMed  CAS  Google Scholar 

  51. Foresta C, Caretta N, Rossato M, et al. Role of androgens in erectile function. J Urol. 2004;171:2358–62.

    Article  PubMed  CAS  Google Scholar 

  52. Saad F, Grahl AS, Aversa A, et al. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJUI. 2007;99:968–92.

    Article  Google Scholar 

  53. Aversa A, Isidori AM, Spera G, Lenzi A, et al. Androgens improve cavernous vasodilatation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632–8.

    Article  CAS  Google Scholar 

  54. Shabsigh R, Kaufman KJ, Steidle C, et al. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172:658–63.

    Article  PubMed  CAS  Google Scholar 

  55. Greenstein A, Mabjeesh NJ, Sofer M, et al. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed? J Urol. 2005;173:530–2.

    Article  PubMed  CAS  Google Scholar 

  56. Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST Study). J Sex Med. 2011;8:284–93.

    Article  PubMed  CAS  Google Scholar 

  57. Morales A, Schulman CC, Tostain JC, Wu WF. Testosterone deficiency syndrome (TDS) need to be named appropriately: the importance of accurate terminology. Eur Urol. 2006;50:407–9.

    Article  PubMed  Google Scholar 

  58. Morales A, Black A, Emerson L, et al. Androgens and sexual function: a placebo controlled, randomized, double blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. Aging Male. 2009;12:104–12.

    Article  PubMed  CAS  Google Scholar 

  59. Guay A, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial of clomiphene citrate. J Clin Endocrinol Metab. 1995;80:3546–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr. Alvaro Morales has received honoraria and payment for the development of educational presentations from Abbott Laboratories.

Author information

Authors and Affiliations

  1. Centre for Applied Urological Research, Queen’s University, 62 Barrie Street, Kingston, Ontario, K7L 3J7, Canada

    Alvaro Morales

Authors
  1. Alvaro Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alvaro Morales.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morales, A. Androgens are Fundamental in the Maintenance of Male Sexual Health. Curr Urol Rep 12, 453–460 (2011). https://doi.org/10.1007/s11934-011-0202-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-011-0202-4

Keywords

Search

Navigation